MS News & Perspectives

MS News & Perspectives

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(500)

Newer Neurologic Therapies Costly & Planning Christmas With MS

Newer Neurologic Therapies Costly & Planning Christmas With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news piece on how fewer than 1 in 5 people with MS or other neurologic conditions in the U.S. are on new-to-market medic...

14 Des 20228min

Climate Change Risk to MS Patients & Finding a Balance That Works

Climate Change Risk to MS Patients & Finding a Balance That Works

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how climate change can worsen symptoms and risk relapses in people with MS.
 He also reads “Sweeter Than Ho...

12 Des 202210min

More Inflammation Biomarkers in PPMS Patients & Brain Shrinkage and Other MS News

More Inflammation Biomarkers in PPMS Patients & Brain Shrinkage and Other MS News

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reports on how individuals with PPMS have significantly higher concentrations of specific inflammation biomarkers in their spina...

9 Des 202210min

Add-on Supplement May Bolster Interferon Therapies & Amazon Does Medical Care

Add-on Supplement May Bolster Interferon Therapies & Amazon Does Medical Care

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on a dietary supplement called Neuroaspis plp10 that significantly lowered relapse rates and slowed disabil...

7 Des 202210min

NVG-291 Dosing Completes & Balancing Self-pity and Grace

NVG-291 Dosing Completes & Balancing Self-pity and Grace

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a trial testing NVG-291 has completed dosing in a final group of healthy postmenopausal women. He ...

5 Des 202210min

Panel Calls for New Way to Classify MS & EBV Vaccine and Other MS News

Panel Calls for New Way to Classify MS & EBV Vaccine and Other MS News

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about the calls for new methods to classify MS that reflect the disease's underlying biology. He also reads “MS News Not...

2 Des 202210min

Vidofludimus Calcium Thwarts Disability Progression & The MS Hug

Vidofludimus Calcium Thwarts Disability Progression & The MS Hug

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how relapsing-remitting MS patients have not had a confirmed disability progression following two years ...

30 Nov 20228min

Life Expectancy Declines Linked to MS Disability & Managing an Urinary Tract Infection

Life Expectancy Declines Linked to MS Disability & Managing an Urinary Tract Infection

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how MS patients without substantial disability live about 30 years past their diagnosis, while survival ...

28 Nov 202211min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
sinnsyn
liberal-halvtime
forskningno
jss
fjellsportpodden
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
dekodet-2
rss-overskuddsliv
rss-inn-til-kjernen-med-sunniva-rose
rss-zahid-ali-hjelper-deg
villmarksliv
nevropodden
rss-rekommandert
hva-er-greia-med
kvinnehelsepodden
vett-og-vitenskap-med-gaute-einevoll